Loading

JSM Sexual Medicine

Behavior of the Respiratory Gases along Ergospirometry in Transgender Women after Long Term Hormone Therapy: A Cross Sectional Study

Research Article | Open Access | Volume 8 | Issue 1

  • 1. Department of Developmental Endocrinology Unit, University of São Paulo Hospital das Clínicas, Brazil
  • 2. Department of Medicine Course, Centro Universitário São Camilo, Brazil
  • 3. Department of Cardiac Rehabilitation and Exercise Physiology Unit, University of São Paulo Heart Institute, Brazil
+ Show More - Show Less
Corresponding Authors
Leonardo Azevedo Mobilia Alvares, Laboratory of Hormones and Molecular Genetics LIM42, Hospital das Clínicas, Faculty of Medicine of USP, Av. Dr. Eneias de Carvalho, Aguiar, 155, PAMB, 2nd floor, block 6, São Paulo, SP, Brazil, 05403-900, Brazil, Tel: 55 11 2661 7512; Fax: 55 11 2661 7519.
Abstract

For transgender women (TW) undergoing estrogen therapy (ET), physiological responses while exerting physical effort is unknown at many points.

Objective: To evaluate the behavior of respiratory gases along with ergospirometry in TW undergoing long-term GAHT

Methods: A cross-sectional study was carried out with 15 TW (34.2±5.2 yo), 14 cisgender men (CM) and 13 cisgender women (CW). The TW received ET for 14.4 ±3.5 years. Ergospirometric test was performed.

Results: Expiratory volume (VE) was similar among groups in the rest and AT points, and an approximation was observed between the pattern of TW and CW at the peak (P>0.05), both lower than CM (TW vs CM p0.05). The end-tidal CO2 partial pressure (PetCO2) of TW was similar to that of CW during the test (p>0.05), and both were lower than that of CM at all points (p0.05 at peak.

Discussion: The physiological curves of respiratory parameters of TW were mostly similar to the CW group. The VE pattern may be a consequence of ET. The VE/VO2 and VE/CO2 show that TW are adapted to this new condition.

Conclusion: The behavior of TW gases during exertion showed a similar physiological pattern to CW.

Keywords

• Transgender

• Exercise test

• Women

CITATION

Alvares LAM, Santos MR, Souza FR, Santos LM, Mendonca BB, et al. (2024) Behavior of the Respiratory Gases along Ergospirometry in Transgender Women after Long-Term Hormone Therapy: A Cross-Sectional Study. JSM Sexual Med 8(1): 1131.

INTRODUCTION

There are physiological differences in respiratory function between males and females. Sex hormones are involved in the regulation of lung maturation [1], and are observed in both the upper and lower air pathways.

Anatomical differences have been described in the upper airways [2-4], with almost all structures being larger in cisgender men (CM) than in cisgender women (CW). The tracheal cross- sectional area is 29% larger in CM, and in general, the luminal areas of the airways are 14-31% larger in CM [5].

CW have smaller airways relative to lung size than men [6], smaller rib cages [7,8] and smaller dimensions of the chest wall [9].

Since birth, females have smaller lungs than males, with fewer respiratory bronchioles [10], and such differences persist throughout life. As a consequence of the higher area, CM has a larger total number of alveoli and a larger alveolar surface area [11].

These structural differences are associated with functional differences during spontaneous breathing and exercise.

Since such aspects and differences in the structure and function of the respiratory system become critically important during exercise, sex differences in respiratory gas patterns during effort have also been described in recent decades.

In recent years, there has been an increase in the number of transgender women (TW) in sports. Thus, we aim to provide a detailed and comprehensive description of the physiological determinants of respiratory patterns in TW. Because of the complex dynamics of the respiratory system during effort and the known differences between sexes, in-depth analyzes of respiratory gases are necessary.

We hypothesized that TW, who underwent male puberty and are undergoing long-term GAHT, have different respiratory adaptations than CW and CM.

METHODS

The study design and methods have been published previously [15]. The study protocol, available with the full text of this article at https://bjsm.bmj.com, was approved by the Ethical Committee of Clinics Hospital of the Medical School of the University of São Paulo (CH-MSUSP). Written informed consent was obtained from all patients (CAAE 17138719.0.0000.0068).

The evaluators were not blinded, with the exception of those who evaluated the results of the cardiopulmonary exercise tests.

Definitions

Transgender Group: In brief, this cross-sectional study, evaluated 15 TW (average age of 34.2 years old, SD ±5.2; average time of GAHT 14.4 years, SD ±3.5) recruited at the Gender Dysphoria Unit of the Division of Endocrinology of Hospital das Clínicas from the Faculty of Medicine of the University of São Paulo. They compared to cisgender control group composed of 27 healthy subjects, of which 13 were CW (35.6±4.1 years of age) and 14 were CM (36.7±3.8 years of age) [Supplementary Table 1,2] matched by age, body mass index (BMI, weight/ [height] 2; (kg/m2) and physical activity level to the TW group according to the International Physical Activity Questionnaire (IPAQ) [12-14] [Supplementary Tables 4 and 5].

All the subjects underwent hormonal tests at the Laboratório de Hormônios e Genética Molecular LIM42 of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, body composition assessment by an In Body 720 device (Biospace, Korea) with an 8-point reading through a tactile electrode and ergospirometric test that will be described below.

Cardiopulmonary Assessment: In this article, we focus on these specific parameters: VE (pulmonary ventilation), VCO (CO production), VE/VO2 (ventilatory equivalents for oxygen), VE/VCO2 (ventilatory equivalents for carbon dioxide), VO2/FFM, VO2/ weight, PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-Tidal CO2 partial pressure).

Ergospirometry test: All individuals performed cardiopulmonary exercise testing (Sensor Medics - Vmax Analyser Assembly, Encore 29S) on a treadmill (Ergoline - Via Sprint 150 P) with incremental effort until exhaustion (ramp protocol). During cardiopulmonary exercise testing, cardiovascular performance was continuously evaluated through electrocardiography (Micromed – Cardio PC 13) with twelve leads simultaneously. Any observed electrocardiographic alteration that might compromise the experimental protocol excluded the individual from the study. The maximum functional capacity was determined by peak oxygen consumption (VO2 peak) evaluated at the maximum exercise intensity. The criteria used to consider the ergospirometry test as maximum were a respiratory exchange ratio (RER) > 1.10 and/or maximum heart rate (HRmax) > 95% of the age-predicted HRmax. The anaerobic threshold (AT) was determined at the time the individual presented the lowest ventilatory equivalent value for O2 (VEO2 ) and partial oxygen pressure at the end of expiration (PO2 ) (PetO2 ), before these parameters started to progressively increase, and a nonlinear increase in the RER value. The respiratory compensation point (RCP) was determined at the time the individual presented the lowest value of ventilatory equivalent for CO2 (VECO2 ), before this parameter started to progressively increase, and the maximum value of partial pressure for CO2 at the end of expiration ( PCO2 ) (PetCO2 ), before initiating a progressive decrease in this response.

Ergospirometry tests were carried out by the Cardiovascular Rehabilitation and Exercise Physiology Unit of Instituto do Coração, Hospital das Clinicas of the Faculty of Medicine of the University of São Paulo.

Statistical Analysis

Due to the lack of previous data to guide the sample size estimation, a convenience sample was used. Statistical analysis was performed using GraphPad Prisma 8.4.2. The D’Agostino and Pearson test was used to evaluate whether the variables were parametric or nonparametric. For parametric variables, comparison among the three groups was done through ANOVA, and for comparative sub analyses of each two groups, the Tukey test was used. The Kruskal–Wallis test was used for nonparametric variables and Dunn’s multiple comparison tests was used for comparative sub analyses of two groups. A p value<0.05 was considered indicative of statistical relevance in all tests There was not missing data.

RESULTS

Laboratory Analysis

The Supplementary Table 2, adapted from Alvares [15], shows the haemoglobin levels (g/dL) of the TW, CW and CM were 14.0 ± 0.6, 13.8 ± 0.6 and 15.3 ± 1.1, respectively.

Hormonal Date

On the day of sporting ability analysis, the mean TT (ng/dL) levels of the TW, CW and CM were 92.5 (range 12-637), 20.1 (12-41) and 524.3±169.0, respectively 

One of the participants had a high level of testosterone at the time of the study. Although she was not blocked on the test day (total testosterone =637 ng/dL), her value was 79 ng/ dL six months before the study [Supplementary Figure 1,2]. In addition, this point did not interfere with her VO2 results [Supplementary Figure 3].

Level of Physical Activity

The level of physical activity was similar among all groups (TW vs. CW, p>0.05; TW vs. CM, p>0.05; CW vs. CM, p=>0.05), with most participants being active or very active in all groups [Supplementary Table 5].

Gases Analysis

All volunteers reached RER > 1.10.

Table 1 shows the main statistical analysis of this study (Figures 1-4).

Table 1: Behavior of the respiratory gases along ergospirometry in transgender women compared to cisgender woman and cisgender man groups.

 

Transgender women (n=15)

Cisgender women (n=13)

Cisgender men (n=14)

Comparison

P

VO2/FFM (ml/kg/min)

 

 

 

 

 

 

Rest

 

5.5 (range 4.5-8.0)

 

6.0 (range 4.3-7.8)

 

2.9 (range 2.3-5.1)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

AT

 

29.5 (range 23.7-59.9)

 

31.2 (range 25.0-40.2)

 

29.4 (SD±6.5)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

RCP

 

43.5 (SD±5.3)

 

44.1 (SD±15.0)

 

45.8 (SD±6.8)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

Peak

 

47.3 (SD±5.1)

 

53.3 (SD±8.3)

 

52.4 (SD±5.8)

TW x CW

NS

TW x CM

NS

CW x CM

NS

VO2/Wgt (ml/kg/min)

 

 

 

 

 

 

Rest

 

2.9 (range 2.3-5.1)

 

2.4 (SD±0.3)

 

3.3 (range 2.2-9.5)

TW x CW

**

TW x CM

NS

CW x CM

****

 

AT

 

21.5 (SD±3.9)

 

22.1 (SD±3.0)

 

21.6 (range 17.1-41.6)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

RCP

 

30.9 (SD±5.0)

 

33.7 (range 25.7-60.3)

 

36.2 (SD±6.7)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

Peak

 

33.5 (SD±4.7)

 

35.7 (SD±4.7)

 

42.0 (range 32.3-49.2)

TW x CW

NS

TW x CM

**

CW x CM

**

VCO2(L/min)

 

 

 

 

 

 

Rest

 

0.25 (SD±0.05)

 

2.05 (SD±0.02)

 

0.28 (range 0.20– 0.82)

TW x CW

*

TW x CM

NS

CW x CM

***

 

AT

 

1.51 (range 0.97-2.7)

 

1.10 (SD±0.22)

 

1.6 (SD±0.39)

TW x CW

*

TW x CM

NS

CW x CM

***

 

RCP

 

2.61 (SD±0.44)

 

2.06 (SD±0.35)

 

3.2 (SD±0.66)

TW x CW

**

TW x CM

**

CW x CM

****

 

Peak

 

2.92 (SD±0.51)

 

2.57 (SD±0.57)

 

3.95 (SD±0.62)

TW x CW

NS

TW x CM

****

CW x CM

****

VE (BTPS) (L/min)

 

 

 

 

 

 

Rest

 

12.3 (SD±2.4)

 

10.0 (SD±1.5)

 

11.8 (SD±3.0)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

AT

 

47.7 (SD±12.1)

 

36.6 (SD±7.6)

 

43.5 (SD±13.4)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

RCP

 

83.5 (SD±12.8)

 

66.1 (SD±11.1)

 

92.1 (SD±19.7)

TW x CW

*

TW x CM

NS

CW x CM

***

 

Peak

 

102.3 (SD±16.2)

 

87.4 (SD±10.2)

 

128.8 (SD±18.7)

TW x CW

NS

TW x CM

**

CW x CM

****

VE/VO2

 

 

 

 

 

 

Rest

 

40.5 (SD±5.0)

 

43.6 (SD±8.6)

 

35.1 (SD±6.6)

TW x CW

NS

TW x CM

NS

CW x CM

**

 

AT

 

28.0 (range 24.0-39.0)

 

28.4 (SD±3.0)

 

24.2 (SD±2.6)

TW x CW

NS

TW x CM

**

CW x CM

**

 

RCP

 

35.0 (range 30.0-48.0)

 

35.4 (SD±3.6)

 

30.0 (range 27.0-42.0)

TW x CW

NS

TW x CM

NS

CW x CM

*

 

Peak

 

39.2 (SD±4.4)

 

42.1 (SD±4.3)

 

38.9 (SD±4.3)

TW x CW

NS

TW x CM

NS

CW x CM

NS

VE/VCO2

 

 

 

 

 

 

Rest

 

49.2 (range 42.0-57.0)

 

50.6 (SD±9.4)

 

40.5 (SD±6.3)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

AT

 

32.0 (SD±3.7)

 

32.1 (SD±3.1)

 

28.0 (SD±3.1)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

RCP

 

32.6 (SD±4.1)

 

32.9 (SD±2.6)

 

28.7 (SD±4.6)

TW x CW

NS

TW x CM

NS

CW x CM

NS

 

Peak

 

32.8 (SD±4.4)

 

33.9 (SD±3.2)

 

30.0 (SD±3.3)

TW x CW

NS

TW x CM

NS

CW x CM

NS

PetO2 (mmHg)

 

 

 

 

 

 

Rest

 

100.6 (SD±3.7)

 

100.5 (SD±3.3)

 

969.8 (SD±4.1)

TW x CW

NS

TW x CM

*

CW x CM

NS

 

AT

 

95.69 (SD± 4.3)

 

95.4 (SD±2.8)

 

90.9 (SD±4.0)

TW x CW

NS

TW x CM

**

CW x CM

*

RCP

102.8 (SD±4.1)

103.7 (SD±2.7)

100.3 (SD±3.1)

TW x CW

NS

 

Peak

 

 

106.4 (SD±4.5)

 

 

108.2 (SD±2.5)

 

 

105.6 (SD±3.9)

TW x CM

NS

CW x CM

NS

TW x CW

NS

 

 

 

 

TW x CM

NS

 

 

 

 

CW x CM

NS

PetCO2 (mmHg)

 

 

 

 

 

 

Rest

 

29.7 (SD±2.7)

 

30.5 (SD±2.5)

 

33.7 (SD±3.7)

TW x CW

NS

TW x CM

**

CW x CM

*

 

AT

 

35.3 (SD± 3.7)

 

34.9 (SD±1.7)

 

40.1 (SD±3.2)

TW x CW

NS

TW x CM

***

CW x CM

***

 

RCP

 

34.2 (SD±4.2)

 

33.7 (SD±2.6)

 

37.9 (SD±3.5)

TW x CW

NS

TW x CM

*

CW x CM

**

Peak

 

 

 

TW x CW

NS

 

32.2 (SD±4.4)

32.1 (SD±3.1)

35.5 (SD±4.3

TW x CM

NS

 

 

 

 

CW x CM

NS

VO2: oxygen consumption; L/min: litre per minute; ml/kg/min: millilitre per kilogram per minute; AT: anaerobic threshold; RCP: respiratory compeNSation point; FFM: fat-free mass; Wgt: weight; VE: volume of expired air; BTPS: body temperature pressure, saturated; VE/VO2 (ventilatory equivalents for oxygen), VE/VCO2 (ventilatory equivalents for carbon dioxide); VCO2: carbon dioxide production VCO2: carbon dioxide production; PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-tidal CO2 partial pressure); mmHg: millimetres of mercury TW: transgender women; CW: cisgender women; CM: cisgender men; NS: non-significant; *p<0.05; **p<0.01; ***p<0.001****p<0.0001.

Comparative analysis of VO2/FFM and VO2/weight VO2/FFM from rest to peak during effort in the 3 groups of transgender women,  cisgender women and cisgender men during incremental effort from rest to exhaustion. VO2/ FFM (A), VO2/ weight (B). VO2: oxygen consumption; FFM: fat-free mass; Wgt: weight; ml/kg/min: millilitre per kilogram per minute; AT: anaerobic threshold; RCP:  respiratory compensation point; ns: non-significant; **p<0.01; ****p<0.0001.

Figure 1: Comparative analysis of VO2/FFM and VO2/weight VO2/FFM from rest to peak during effort in the 3 groups of transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. VO2/ FFM (A), VO2/ weight (B). VO2: oxygen consumption; FFM: fat-free mass; Wgt: weight; ml/kg/min: millilitre per kilogram per minute; AT: anaerobic threshold; RCP: respiratory compensation point; ns: non-significant; **p<0.01; ****p<0.0001.

Comparative analysis of pulmonary ventilation and carbon dioxide production from rest to peak during effort in the 3 groups of  transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. VE (BTPS) (A), VCO2 (B). VE: pulmonary ventilation; BTPS: body temperature, pressure, water vapor saturated; VCO2: carbon dioxide production; L/min: litre per minute;  AT: anaerobic threshold; RCP: respiratory compensation point; ns: non-significant; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Figure 2: Comparative analysis of pulmonary ventilation and carbon dioxide production from rest to peak during effort in the 3 groups of transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. VE (BTPS) (A), VCO2 (B). VE: pulmonary ventilation; BTPS: body temperature, pressure, water vapor saturated; VCO2: carbon dioxide production; L/min: litre per minute; AT: anaerobic threshold; RCP: respiratory compensation point; ns: non-significant; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Comparative analysis VE/VO2 and VE/VCO2 from rest to peak during effort in the 3 groups of transgender women, cisgender women and  cisgender men during incremental effort from rest to exhaustion. VE/VO2 (A), VE/VCO2 (B). VE/VO2 (ventilatory equivalents for oxygen), VE/VCO2 (ventilatory equivalents for carbon dioxide); L/min: litre per minute; AT: anaerobic  threshold; RCP: respiratory compensation point; ns: non-significant

Figure 3: Comparative analysis VE/VO2 and VE/VCO2 from rest to peak during effort in the 3 groups of transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. VE/VO2 (A), VE/VCO2 (B). VE/VO2 (ventilatory equivalents for oxygen), VE/VCO2 (ventilatory equivalents for carbon dioxide); L/min: litre per minute; AT: anaerobic threshold; RCP: respiratory compensation point; ns: non-significant

Comparative analysis PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-tidal CO2 partial pressure) from rest to peak during  effort in the 3 groups of transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. PetO2 (A),  PetCO2 (B). PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-tidal CO2 partial pressure); mmHg: millimetres of mercury. AT: anaerobic threshold;  RCP: respiratory compensation point; ns: non-significant; *p<0.05; **p<0.01; ***p<0.001.

Figure 4: Comparative analysis PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-tidal CO2 partial pressure) from rest to peak during effort in the 3 groups of transgender women, cisgender women and cisgender men during incremental effort from rest to exhaustion. PetO2 (A), PetCO2 (B). PetO2 (End-Tidal Partial Pressure of Oxygen) and PetCO2 (End-tidal CO2 partial pressure); mmHg: millimetres of mercury. AT: anaerobic threshold; RCP: respiratory compensation point; ns: non-significant; *p<0.05; **p<0.01; ***p<0.001.

Body Composition Analysis

The FFM of the TW (55.1±5.5 kg) was intermediate between the CW (40.6±4.1kg) and CM (63.7±5.4 kg) (TWvsCW p<0.0001; TWvsCM p<0.001; and the CMvsCW p p<0.0001).

DISCUSSION

This is the first study to demonstrate the respiratory physiology from de rest to the peak of respiratory parameters in TW undergoing ergoespirometric test and complement the previous published data on VO2peak of this group [15].

VE is the volume of air moved in and out of the lungs (respiratory rate x tidal) [17]. At rest, the TW group was similar to the other groups, and during effort, the CW and TW patterns were similar. This means that the possibility of expanding flow resembled the female pattern.

The volume variations in male lungs are larger than those in female lungs [18,19]. Men have significantly larger mean values for all pulmonary variables, both volumes and flows [1]. The differences between women and men impact the development of flow, the regulation of lung volume, pressure swings and the consequent work of breathing.

Estrogen can be associated with the reduction of these respiratory values. A translational study demonstrated that tidal volume was significantly increased in male wild-type mice compared with female wild-type mice; however, this pattern was reversed in alpha-ERKO mice (estrogen receptor knockout) [8]. These data suggest that functional disruption of ER-alpha leads to changes in a variety of respiratory parameters and that this nuclear receptor may be a critical regulator of breathing and respiratory rhythmogenesis in mice [2].

Females’ smaller airway diameter and lung volume result in lower peak expiratory flow and vital capacity. Therefore, women have a smaller maximal flow-volume loop. Their capacity to generate increased ventilation during exercise is smaller than men’s.

The regulation of lung volume during exercise is an important factor, as it reflects the strategy by which tidal volume is achieved and contributes to the work of breathing.

The smaller female vital capacity implies a lower maximal tidal volume to be achieved during exercise, compensated for by a higher respiratory rate to adequately ventilate the lungs. The volume of CO2 produced by TW from rest to exhaustion demonstrated a peculiar pattern, being different from the value in the other groups in most analyses.

VE/VO2 , the ratio between pulmonary ventilation and O2 consumption [17], presented the same pattern in CW and CM described in the literature, and TW presented the same pattern as the CW group. Since VE/VO2 reflects the ventilatory need for a certain O2 consumption level [17], we can observe that, despite the possible anatomical changes, the ventilatory efficiency is preserved in TW.

In the same way, VE/VCO2 , which represents the ventilatory need to eliminate a certain amount of CO2 produced by active tissues [17], at rest, AT and RCP were similar between the 3 groups. At the peak, they presented the patterns already described, and no difference was seen between groups.

VO2 peak/FFM is the best way to show VO2 functional status because it evaluates the physiological ability of the tissue to uptake oxygen. This ratio of TW group was statistically equal of the other groups at all points, which.

The PETO2 of TW was similar to the CW pattern at rest, and during exercise, both patterns approached the CM pattern. The same was observed in PETCO2 . The perfusion within the pulmonary system of TW was in the female pattern.

In this study, we describe that TW without a history of pulmonary and/or cardiac diseases on prolonged use of hormone therapy have a VE [Supplementary Table 3], with an intermediate value between the values of CM and CW. One explanation for this different VE pattern in TW would be a reduction of the caliber of the airways by estrogen, which is a potential bronchoconstrictor [2].

LIMITATIONS

Our study sample is not a true random sample and was made of volunteers because the casuistry is hard to find, which can be a weak point of our study. However, we believe that the approach of the current study in developing models could be done in other places of the world. Since this study analysed active transgender, the presented findings cannot be extrapolated to athletes.

 

CONCLUSION

In this small cohort of nonathletic TW, who previously underwent male pubertal development followed by long-term estrogen therapy, the behavior of gases and heart rate during exertion, analyzed through ergospirometry, showed a similar physiological pattern to that of CW in most analyses. Changes in anatomy and functional phenotypes caused by estrogen have been elucidated by in-depth physiological studies

ACKNOWLEDGEMENTS

The authors are grateful to the Gender Dysphoria Unit of the Division of Endocrinology of Hospital de Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), Laboratório de Hormônios LIM42 do HCFMUSP and Instituto do Coração (InCor) do HCFMUSP.

Funding sources

This research was supported by grants from the Coordination for the Improvement of Higher Education Personnel (CAPES/ PNPD; institutional fellowship Grant 88887.362860/2019-00 to LAMA), and by National Council for Scientific and Technological Development (CNPq) Grants 308873/2018-1 (to SD).

Data sharing statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Authors’ contributions

Study conception and design: Alvares LAM, Domenice S; Data acquisition and analysis: Alvares LAM, Santos MR, Souza FR, Santos LM, Alves MJNN; Manuscript drafting: Alvares LAM, Domenice S; Critical revision: Domenice S, Costa EMF, Mendonca BB.

Ethics

This study was approved by the Ethical Committee of Clinics Hospital of the Medical School of the University of São Paulo (CH-MSUSP). Written informed consent was obtained from all patients (CAAE 17138719.0.0000.0068).

Patient involvement

None or not applicable 

Questions and Answers

- What are the new findings?

This article shows an in-depth analysis of the gaseous behavior of transgender women during effort.

- How might it impact clinical practice in the near future?

These findings could help in analyses of respiratory parameters of transgender women during rest and effort.

-What is already known about this topic?

There are no data about the physiological behavior of gases of transgender women.

-What this study adds?

This study adds to our knowledge about respiratory physiology in transgender women 

REFERENCES
  1. Seaborn T, Simard M, Provost PR, Piedboeuf B, Tremblay Y. Sex hormone metabolism in lung development and maturation. Trends Endocrinol Metab. 2010; 21: 729-738.
  2. Card JW, Zeldin DC. Hormonal influences on lung function and response to environmental agents: lessons from animal models of respiratory disease. Proc Am Thorac Soc. 2009; 6: 588-595.
  3. Rowley JA, Sanders CS, Zahn BR, Safwan Badr M. Gender differences in upper airway compliance during NREM sleep: role of neck circumference. J Appl Physiol. 2002; 92: 2535-2541.
  4. Brown IG, Zamel N, Hoffstein V. Pharyngeal cross-sectional area in normal men and women. J Appl Physiol. 1986; 61: 890-895.
  5. Sheel AW, William Sheel A, Dominelli PB, Molgat-Seon Y. Revisiting dysanapsis: sex-based differences in airways and the mechanics of breathing during exercise. Exp Physiol. 2016; 101: 213-218.
  6. Mead J. Dysanapsis in normal lungs assessed by the relationshipbetween maximal flow, static recoil, and vital capacity. Am Rev Respir Dis. 1980; 121: 339-342.
  7. Bellemare JF, Cordeau MP, Leblanc P, Bellemare F. Thoracic Dimensions at Maximum Lung Inflation in Normal Subjects and in Patients with Obstructive and Restrictive Lung Diseases. Chest. 2001; 119: 376-386.
  8. Bellemare F, Jeanneret A. Sex differences in thoracic adaptation to pulmonary hyperinflation in cystic fibrosis. Eur Respir J. 2007; 29: 98-107.
  9. Romei M, Mauro AL, D’Angelo MG, Turconi AC, Bresolin N, Pedotti A, et al. Effects of gender and posture on thoraco-abdominal kinematics during quiet breathing in healthy adults. Respir Physiol Neurobiol. 2010; 172: 184-191.
  10. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax. 1999; 54: 1119-1138.
  11. Thurlbeck WM. Postnatal human lung growth. Thorax. 1982; 37: 564- 571.
  12. Matsudo SM, Matsudo VR, Araujo T. Nível de atividade física da população do Estado de São Paulo: análise de acordo com o gênero, idade, nível socioeconômico, distribuição geográfica e de conhecimento. Rev Bras Cienc Mov. 2002; 10: 41-50.
  13. Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira LC, et al. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Fis Saúde. 2001; 6: 5-18.
  14. Matsudo SM, Matdsudo VR, Araújo T, Andrade D, Andrade E, Oliveira L, et al. Nível de atividade física da população do Estado de São Paulo: análise de acordo com o gênero, idade, nível socioeconômico, distribuição geográfica e de conhecimento. Rev Bras Cienc Mov. 2002; 10: 41-50.
  15. Alvares LAM, Santos MR, Souza FR, Santos LM, Mendonça BB de, Costa EMF, et al. Cardiopulmonary capacity and muscle strength in transgender women on long-term gender-affirming hormone therapy: a cross-sectional study. Br J Sports Med. 2022; 56: 1292- 1298.
  16. Cerqueira LS, Nogueira FS, Carvalho J, Pompeu FAM. Resposta da cinética de consumo de oxigênio e da eficiência mecânica delta de homens e mulheres em diferentes intensidades de esforço [Internet]. Revista Brasileira de Medicina do Esporte. 2011; 17: 274-278.
  17. Herdy AH, Ritt LEF, Stein R, Araújo CGS de, Milani M, Meneghelo RS, et al. Cardiopulmonary Exercise Test: Background, Applicability and Interpretation. Arq Bras Cardiol. 2016; 107: 467-481.
  18. Quanjer PH, Hall GL, Stanojevic S, Cole TJ, Stocks J. Age- and height- based prediction bias in spirometry reference equations. Eur Respir J. 2012; 40: 190-197.
  19. Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry. Eur Respir J. 2013; 42: 1046-1054..

Alvares LAM, Santos MR, Souza FR, Santos LM, Mendonca BB, et al. (2024) Behavior of the Respiratory Gases along Ergospirometry in Transgender Women after Long-Term Hormone Therapy: A Cross-Sectional Study. JSM Sexual Med 8(1): 1131.

Received : 05 Dec 2023
Accepted : 27 Jan 2024
Published : 29 Jan 2024
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X